In the last decades the metabolic syndrome (MS) has become one of the most important pathologies and cause of death in industrialized countries. According to the WHO, the MS is characterized by abdominal obesity, dyslipidemia, hypercholesterolemia, artery hypertension and insulin resistance. Perspective studies carried out in Italy show that about 19% of people over 45,